Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque

NCT ID: NCT04921371

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

157 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-08

Study Completion Date

2019-12-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the safety and efficacy of experimental mouth rinse formulations compared to a positive control mouth rinse and a hydroalcohol control mouth rinse for the reduction of gingivitis and plaque when used as an adjunct to tooth brushing during a six-week product usage period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis Plaque

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Reference Group

Participants who are identified as healthy will be a comparison group. This group will participate in the examinations and plaque sampling only and will not receive a prophylaxis or product.

Group Type OTHER

Colgate® Cavity Protection Toothpaste

Intervention Type OTHER

Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.

Concept Curve Winter Series Toothbrush

Intervention Type OTHER

Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.

5% Hydroalcohol Mouthrinse (Negative control)

Participants after brushing with Colgate® Cavity protection toothpaste and Concept Curve winter series toothbrush will rinse mouth for 30 seconds with 20 milliliter (mL) of 5 percent (%) Hydroalcohol Mouthrinse twice daily (morning and evening) up to 6 weeks.

Group Type EXPERIMENTAL

Colgate® Cavity Protection Toothpaste

Intervention Type OTHER

Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.

Concept Curve Winter Series Toothbrush

Intervention Type OTHER

Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.

5% Hydroalcohol Mouthrinse

Intervention Type OTHER

Participants will use 20 mL of 5% Hydroalcohol Mouthrinse for 30 seconds after brushing twice daily.

Listerine® Cool Mint® (Positive control)

Participants after brushing with Colgate® Cavity protection toothpaste and Concept curve winter series Toothbrush will rinse mouth for 30 seconds with 20 mL of Listerine® Cool Mint® twice daily (morning and evening) up to 6 weeks.

Group Type EXPERIMENTAL

Colgate® Cavity Protection Toothpaste

Intervention Type OTHER

Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.

Listerine® Cool Mint®

Intervention Type OTHER

Participants will use 20 mL of Listerine® Cool Mint® mouth rinse for 30 seconds after brushing twice daily.

Concept Curve Winter Series Toothbrush

Intervention Type OTHER

Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.

Mouthrinse Prototype 1

Participants after brushing with Colgate® Cavity protection toothpaste and Concept Curve winter series toothbrush will rinse mouth for 30 seconds with 20 mL of Mouthrinse Prototype 1 twice daily (morning and evening) up to 6 weeks.

Group Type EXPERIMENTAL

Colgate® Cavity Protection Toothpaste

Intervention Type OTHER

Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.

Concept Curve Winter Series Toothbrush

Intervention Type OTHER

Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.

Mouthrinse Prototype 1

Intervention Type OTHER

Participants will use 20 mL of Mouthrinse Prototype 1 for 30 seconds after brushing twice daily.

Mouthrinse Prototype 2

Participants after brushing with Colgate® Cavity protection toothpaste and Concept Curve winter series toothbrush will rinse mouth for 30 seconds with 20 mL of Mouthrinse Prototype 2 twice daily (morning and evening) up to 6 weeks.

Group Type EXPERIMENTAL

Colgate® Cavity Protection Toothpaste

Intervention Type OTHER

Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.

Concept Curve Winter Series Toothbrush

Intervention Type OTHER

Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.

Mouthrinse Prototype 2

Intervention Type OTHER

Participants will use 20 mL of Mouthrinse Prototype 2 for 30 seconds after brushing twice daily.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colgate® Cavity Protection Toothpaste

Participants will use Colgate® Cavity protection toothpaste for brushing teeth twice daily.

Intervention Type OTHER

Listerine® Cool Mint®

Participants will use 20 mL of Listerine® Cool Mint® mouth rinse for 30 seconds after brushing twice daily.

Intervention Type OTHER

Concept Curve Winter Series Toothbrush

Participants will brush twice daily for 1 minute with the toothpaste and soft bristled toothbrush provided.

Intervention Type OTHER

5% Hydroalcohol Mouthrinse

Participants will use 20 mL of 5% Hydroalcohol Mouthrinse for 30 seconds after brushing twice daily.

Intervention Type OTHER

Mouthrinse Prototype 1

Participants will use 20 mL of Mouthrinse Prototype 1 for 30 seconds after brushing twice daily.

Intervention Type OTHER

Mouthrinse Prototype 2

Participants will use 20 mL of Mouthrinse Prototype 2 for 30 seconds after brushing twice daily.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adequate oral hygiene (That is brush teeth daily and exhibit no signs or oral neglect)
* A minimum of 20 gradable teeth including 4 molars with scorable facial and lingual surfaces. Teeth that are grossly carious, extensively restored, orthodontically banded, abutments, exhibiting severe generalized cervical and/or enamel abrasion, teeth with veneers, or third molars will not be included in the tooth count
* A mean gingival index greater than or equal to (\>=) 1.95 per the Modified Gingival Index at Baseline (for those in the randomized treatment group)
* A mean gingival index less than or equals to (\<=) 0.75 per the Modified Gingival Index at Baseline (for those in the healthy reference group)
* A mean plaque index \>= 1.95 per the 6 site Turesky modification of the Quigley-Hein Plaque Index at Baseline (for those in randomized treatment groups)
* Greater than or equal to 10 percent (%) bleeding sites at baseline (for those in randomized treatment groups)

Exclusion Criteria

* History of significant adverse effects, including sensitivities or suspected allergies, following use of oral hygiene products such as toothpastes, mouth rinses and red food dye
* Dental prophylaxis within four weeks prior to Screening/Baseline 1 visit
* More than three sites that have periodontal pockets depths measuring 5mm or greater in depth
* Teeth having periodontal pocket depths measuring more than 3 mm in depth (healthy reference group)
* History of medical conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
* Use of Antibiotics, anti-inflammatory or anticoagulant therapy, phenytoin sodium or diphenylhydantoin, calcium channel blockers, cyclosporin A, immunostimulants/ immunomodulators during the study or within the one month prior to the Baseline 1 exam. Intermittent use of certain anti-inflammatory medication is acceptable at the discretion of the Investigator
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johnson & Johnson Consumer Inc. (J&JCI)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeffery Milleman, DDS

Role: PRINCIPAL_INVESTIGATOR

Salus Research, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Salus Research, Inc.

Fort Wayne, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Min K, Glowacki AJ, Bosma ML, McGuire JA, Tian S, McAdoo K, DelSasso A, Fourre T, Gambogi RJ, Milleman J, Milleman KR. Quantitative analysis of the effects of essential oil mouthrinses on clinical plaque microbiome: a parallel-group, randomized trial. BMC Oral Health. 2024 May 18;24(1):578. doi: 10.1186/s12903-024-04365-9.

Reference Type DERIVED
PMID: 38762482 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCSORC001793

Identifier Type: OTHER

Identifier Source: secondary_id

CCSORC001793

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anti-gingivitis Mouthrinse
NCT06048627 COMPLETED PHASE3